CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

January 8th, 2010

Friday Roundup: IMPROVE-IT Pushed Back, Statins not Beneficial for AS, Xience V Approved in Japan, New Format for Scientific Papers

The much-discussed IMPROVE-IT trial comparing the combination of ezetimibe and simvastatin with simvastatin monotherapy in 18,000 patients won’t be completed until June 2013, a year later than previously announced. (Merck press release and FAQ)

Another trial has found that statin therapy, this time using rosuvastatin 40 mg, was not beneficial in aortic stenosis. ASTRONOMER was published online in Circulation earlier this week. The authors conclude that “statins should not be  used for the sole purpose of reducing the progression of AS.”

Abbot announced today that it’s Xience V everolimus-eluting stent has been approved in Japan. (press release)

Cell magazine launched a beta test of an entirely new format for the presentation of scientific articles online. Is this the beginning of the end of print? Read a message from Cell’s editor-in-chief, or view an article in the new format.

Finally, to end the first week of 2010, you will never find a more succinct and humorous explanation of the important distinction between correlation and causation than this 3 panel cartoon. Enjoy.

Categories: General


You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.